Point-of-care viral load testing to manage HIV viraemia during the rollout of dolutegravir-based ART in South Africa: a randomised feasibility study (POwER).

Jienchi Dorward,Yukteshwar Sookrajh,Richard Lessells, Elliot Bulo,Jessica Naidoo,Keshani Naidoo,Nicola Bodley,Mlungisi Khanyile,Claudia Jansen Van Vuuren,Pravikrishnen Moodley,Natasha Samsunder,Lara Lewis,Paul K Drain,Gail Hayward,Christopher C Butler,Nigel Garrett

Journal of acquired immune deficiency syndromes (1999)（2023）

引用 1|浏览29

暂无评分

摘要

It was feasible to conduct a trial of point-of-care VL testing to manage viraemia. Point-of-care VL lead to quicker results and fewer clinical visits, but estimates of 24-week VL suppression were similar between arms.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要